Stay updated on EYP-1901 in NPDR Clinical Trial
Sign up to get notified when there's something new on the EYP-1901 in NPDR Clinical Trial page.

Latest updates to the EYP-1901 in NPDR Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Locations section has been added, listing EyePoint Investigative Sites across Arizona, California, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Massachusetts, Nevada, New Jersey, New York, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Virginia, and Washington. The page revision is v3.3.3.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; page content and layout appear unchanged.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page footer now shows Revision: v3.3.1 instead of v3.2.0; this is a metadata update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the temporary notice about government funding lapses and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedNo significant changes detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedSummary: The page now displays a government funding notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference3%

Stay in the know with updates to EYP-1901 in NPDR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EYP-1901 in NPDR Clinical Trial page.